Walpar Nutritions logo

Walpar Nutritions financials and balance sheet

NSE: WALPARPharmaceuticals & Biotechnology

Last close ₹26.10₹0.00 (0.00%)

Share price at the NSE close on 13 Oct 2026. Previous close ₹26.10.

52-week range of traded prices to 13 Oct 2026
₹21.25Low, 12 Jun 2026₹50.60High, 22 Dec 2025
Market cap
₹25 Cr
P/E
9.9
P/B
1.3
Dividend yield
Nonein the last 12 months
ROE
14.0%
Debt to equity
0.76
Volume, NSE
2,000100.0% delivered

4 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Walpar Nutritions annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹79 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue79
  2. Materials and goods−59
  3. Employee costs−7.1
  4. Other expenses−5.6
  5. Operating profit6.7
  6. Depreciation−2.0
  7. Other income+0.3
  8. Finance costs−0.8
  9. Profit before tax4.1
  10. Joint ventures−0.2
  11. Net profit2.5

What the company owns

  • Receivables₹23 Cr
  • Plant, investments and other assets₹22 Cr
  • Inventory₹15 Cr
  • Cash and bank₹5 Cr

What pays for it: net worth and liabilities

  • Owed to suppliers₹22 Cr
  • Net worth₹22 Cr
  • Borrowings₹17 Cr
  • Other liabilities₹5 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Walpar Nutritions half-yearly results

₹ croreMar 2023Mar 2024Mar 2025Filed 23 FebMar 2026Filed 28 May
Revenue from operations35.162.571.878.8
31.657.866.072.1
Materials and goods bought24.149.856.759.4
Employee costs4.24.04.77.1
Other expenses3.44.04.75.6
Operating profit before depreciation3.54.85.76.7
Operating margin9.9%7.6%8.0%8.5%
Materials, % of revenue68.6%79.6%78.9%75.4%
Employee costs, % of revenue11.8%6.4%6.5%9.0%
Other expenses, % of revenue9.7%6.4%6.5%7.1%
Depreciation and amortisation1.91.81.82.0
Operating profit after depreciation1.62.93.94.6
Other income0.30.20.30.3
Finance costs0.80.70.30.8
One-off items0.00.0––
Profit before tax1.12.53.94.1
Tax–0.5––
Share of profit of joint ventures and associates–––−0.2
Net profit0.61.63.32.5
Net margin1.7%2.5%4.6%3.1%
Net margin without joint ventures and associates–––3.4%
Tax is left blank for the years to Mar 2023, Mar 2025 and Mar 2026: profit before tax less the tax charge stated does not come to the profit after tax the same statement states, so the tax charge is not shown.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2025Filed 23 FebMar 2026Filed 28 May
19.322.1
16.618.9
Share capital9.49.4
Reserves7.29.5
Belonging to outside owners of subsidiaries2.73.2
7.916.8
24.635.0
3.58.9
Total assets47.466.1
12.917.4
34.548.7
Net debt6.311.8
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2023 and Mar 2024, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2025Filed 23 FebMar 2026Filed 28 May
4.061.83
4.685.30
−1.30−1.62
Receivables−7.74−2.27
Inventories−1.38−4.73
Payables6.895.35
Other working capital0.930.03
Tax paid−0.62−0.90
Capital spending2.283.59
Free cash flow1.78−1.76
Cash from investing−2.30−6.57
−0.688.08
Dividends paid0.000.00
Shares issued0.000.00
Net change in cash1.083.34
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2023 and Mar 2024.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2023Mar 2024Mar 2025Filed 23 FebMar 2026Filed 28 May
Earnings per share––₹2.48₹2.64
Diluted earnings per share––₹2.48₹2.64
Book value per share––₹17.63₹20.13
Shareholder yield––0.0%–
Market cap at the year end (₹ crore)22.949.439.7–

Ratios

Consolidated, years to March.Walpar Nutritions PE ratio and valuation

RatioMar 2023Mar 2024Mar 2025Filed 23 FebMar 2026Filed 28 May
Revenue growth–77.9%14.8%9.8%
Operating profit growth–36.0%20.3%16.4%
Net profit growth–168.1%106.8%−24.4%
Earnings per share growth–––6.5%
––19.8%14.0%
–––−5.8 pts
From the net margin–––−6.1 pts
From asset turnover–––−1.1 pts
From borrowing–––1.5 pts
Return on capital employed––14.4%11.9%
Cash conversion––124.0%74.1%
Interest cover2.04.413.55.8
Debt to equity––0.410.76
Receivable days––108109
Inventory days––6894
Payable days––108136
Cash conversion cycle, days––6766
Working capital days––6477
Asset turnover––1.511.39
Assets per rupee of net worth––2.863.20
Sales per rupee of plant––7.00–
Capital spending to depreciation––1.251.78
No balance sheet is on record for the years to Mar 2023 and Mar 2024, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
4.4%
Cash from operations against operating profit
27.5%
Measure5 years3 years
Revenue growth, yearly rate–30.9%
Profit growth, yearly rate–61.3%
Return on equity, average–16.9%
Return on capital employed, average–13.2%
Operating margin, average8.5%8.0%
Net margin, average3.0%3.4%
Asset turnover, average–1.45
Cash conversion cycle, days, average–67
Interest cover, average6.47.9
Debt to equity, average–0.58

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations1.83
Cash from investing−6.57
Cash from financing8.08
Capital spending3.59
Dividends paid0.00
Shares issued for cash0.00
Borrowings raised8.92
Borrowings repaid0.00

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2023Mar 2024Mar 2025Mar 2026
Receivables growth less revenue growthOur threshold 0 percentage points–––0.94
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––40.05
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––4.96
Effective tax ratePublished threshold 17.16 per cent26.7521.9727.8421.84
Tax charged less tax paid, % of profitOur threshold 10 percentage points––11.73−0.08
A threshold marked as ours has no published figure; it is the line we read the check against.